Combination Therapy of Different Antidepressants With Dietary Supplements
NCT05931965 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88
Last updated 2023-09-11
Summary
The aim of this clinical trial is to compare the effect of antidepressants in combination with different dietary supplements in patients with depression. Our main objective is to compare the efficacy of antidepressants in combination with either L-methyl folate, Vit B12, or magnesium) in patients with depressive disorders. The levels of depressive symptoms as measured by the Patient Health Questionnaire (PHQ-9) at base level and during follow-up.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
L-methylfolate
Participants receive L-methylfolate 400µg orally twice daily for 4 weeks
- DIETARY_SUPPLEMENT
-
Vitamin B12
Participants receive mecobalamin 500µg intramuscularly stat on alternate days (6 total injections)
- DIETARY_SUPPLEMENT
-
magnesium
Participants receive magnesium glycinate 400mg twice daily orally for 4 weeks (elemental 120mg approx.)
Sponsors & Collaborators
-
Riphah International University
lead OTHER
Principal Investigators
-
Afifa Siddique, MBBS · IIMC-T, Riphah International University, Rawalpindi
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-05
- Primary Completion
- 2023-07-30
- Completion
- 2023-08-31
Countries
- Pakistan
Study Locations
More Related Trials
-
Adherence to Antidepressant Treatment in Subjects With Depression
NCT03388164 ·Status: TERMINATED ·Phase: PHASE2
-
Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)
NCT00048594 ·Status: COMPLETED ·Phase: PHASE3
-
Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression
NCT00093847 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test Different Doses of BI 1569912 in People With Depression
NCT06558344 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine
NCT03290963 ·Status: WITHDRAWN ·Phase: PHASE2
-
Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression
NCT04469322 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression
NCT00101452 ·Status: COMPLETED ·Phase: NA
-
A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression
NCT01814085 ·Status: COMPLETED ·Phase: PHASE4
-
Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities
NCT05104918 ·Status: UNKNOWN ·Phase: PHASE3
-
Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents With Anxiety and Depression
NCT06853587 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine
NCT04623034 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder
NCT05952713 ·Status: COMPLETED
-
Efficacy of Antidepressants in Chronic Back Pain
NCT00964886 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)
NCT00048607 ·Status: COMPLETED ·Phase: PHASE3
-
Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
NCT05416957 ·Status: COMPLETED ·Phase: PHASE1
-
MRS and Medication Response: A Pilot Study
NCT03254342 ·Status: TERMINATED
-
Neural Responses and Dysphoria: Modulation by a Pharmacological Probe
NCT01101685 ·Status: COMPLETED ·Phase: PHASE4
-
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
NCT01912196 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Aspects of Depression and Antidepressant Drugs
NCT00018733 ·Status: COMPLETED ·Phase: NA
-
Effects of Nutrients Supplementation in Antidepressant Treated Depressive Disorder Patients
NCT04179006 ·Status: UNKNOWN ·Phase: NA
-
Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder
NCT00593879 ·Status: COMPLETED ·Phase: PHASE2
-
The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients
NCT04751071 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients
NCT06126497 ·Status: COMPLETED ·Phase: PHASE2
-
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial
NCT03367533 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)
NCT00759395 ·Status: COMPLETED ·Phase: PHASE2